At the ITMO University in St. Petersburg, Russia researchers have developed a coating of aluminum oxide nanorods combined with a thrombolytic enzyme called urokinase-type plasminogen activator that attracts plasmin, a fibrin clot dissolving enzyme produced by the body.
Researchers at Columbia and Boston University have developed novel methods utilizing image reconstruction and nanometer measurements to delve into complex neuronal structures invisible to the naked eye hitherto. The paper, published in Cell, can be accessed here: http://www.cell.com/cell/abstract/S0092-8674(15)00824-7
Researchers have developed a new model to study motor neuron degeneration and have used this to identify three genes involved in the neurodegeneration process. In our quest to understand diseases like ALS and other forms of neuronal degeneration, these findings could provide to be very helpful.
Second Sight has been engineering innovative biotechnologies to provide eye sight capabilities to the blind population. Although met with great success, researchers have long desired to develop a method to test how well one can see with a bionic eye. Moreover, we are interested in knowing about the experience of the patient utilizing this eye. University of Washington scientists have now developed a method by which patients , and their families, can visualize what it will be like for them to acquire a bionic eye.
The manner in which stem cells transform and obtain their particular characteristics has always been known to be directly related to the cell cycle clock. Scientists in Singapore. The molecular clock controlling this process has now been discovered with precise detail.